Multimodal treatments for advanced prostate cancer
Oncotarget
.
2019 Jan 8;10(3):255-256.
doi: 10.18632/oncotarget.26525.
Authors
Izak Faiena
1
,
Isaac Y Kim
1
,
Thomas L Jang
1
Affiliation
1
Thomas L. Jang: Section of Urologic Oncology, Division of Urology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.
PMID:
30719221
PMCID:
PMC6349456
DOI:
10.18632/oncotarget.26525
No abstract available
Keywords:
combined modality therapy; prostate cancer; radiation; surgery; survival.
Publication types
Editorial